Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 02:15PM GMT
Release Date Price: €117.8 (-3.08%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Hi. Good morning, everybody, and thank you for joining us here for the Barclays Global Virtual Healthcare Conference. I am Kristen Stewart, the medical supplies and devices analyst here at Barclays. I'm very excited to have Johnson & Johnson here for this session.

Just as a reminder, if you want to ask any questions, you can e-mail me directly. You can also chat me on Bloomberg.

Before we kick it off with Ciro Roemer, who's the company group Chairman for Medical Devices in North America, I'm going to turn it over to Matt Stuckley, who's going to read some very riveting information for all of you. So make sure to pay attention. Matt?

Matthew Stuckley
Johnson & Johnson - Senior Director of IR

Thank you, Kristen, for that great introduction. So good morning, everyone.

Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular our 10-K, which discuss

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot